Nevus is a nonspecific medical term for a visible, circumscribed, chronic lesion of the skin or mucosa. The term originates from nævus, which is Latin for "birthmark", however, a nevus can be either congenital or acquired. Common terms, including mole, birthmark, and beauty mark, are used to describe nevi, but these terms do not distinguish specific types of nevi from one another.
Invasive carcinoma of no special type (NST) also known as invasive ductal carcinoma or ductal NOS and previously known as invasive ductal carcinoma, not otherwise specified (NOS) is a group of breast cancers that do not have the "specific differentiating features". Those that have these features belong to other types.
Ductal carcinoma in situ (DCIS), also known as intraductal carcinoma, is a pre-cancerous or non-invasive cancerous lesion of the breast. DCIS is classified as Stage 0. It rarely produces symptoms or a breast lump one can feel, and is usually detected through screening mammography.
Fibrocystic breast changes is a condition of the breasts where there may be pain, breast cysts, and breast masses. The breasts may be described as "lumpy" or "doughy". Symptoms may worsen during certain parts of the menstrual cycle. It is not associated with cancer.
Endometrial hyperplasia is a condition of excessive proliferation of the cells of the endometrium, or inner lining of the uterus.
Ductal lavage is a method used to collect cells from milk ducts in the breast. A hair-size catheter (tube) is inserted into the nipple, and a small amount of salt water is released into the duct. The water picks up breast cells, and is removed. The cells are checked under a microscope. Ductal lavage may be used in addition to clinical breast examination and mammography to detect breast cancer.
Atamestane, also known as metandroden, as well as 1-methylandrosta-1,4-diene-3,17-dione, is a steroidal aromatase inhibitor that was studied in the treatment of cancer. It blocks the production of estrogen in the body. The drug is selective, competitive, and irreversible in its inhibition of aromatase.
Benign proliferative breast disease is a group of noncancerous conditions that may increase the risk of developing breast cancer. Examples include atypical ductal hyperplasia, atypical lobular hyperplasia, and intraductal papillomas.
Breast duct endoscopy is a method used to examine the lining of the lactiferous ducts to look for abnormal tissue. A very thin, flexible, lighted tube attached to a camera is inserted through the nipple, and threaded into the breast ducts deep in the breast. Tissue and fluid samples may be removed during the procedure.
Cholangiosarcoma is a tumor of the connective tissues of the bile ducts.
Stereotactic biopsy, also known as stereotactic core biopsy, is a biopsy procedure that uses a computer and imaging performed in at least two planes to localize a target lesion in three-dimensional space and guide the removal of tissue for examination by a pathologist under a microscope. Stereotactic core biopsy makes use of the underlying principle of parallax to determine the depth or "Z-dimension" of the target lesion.
Thymic carcinoma is a rare type of thymus gland cancer. It usually spreads, has a high risk of recurrence, and has a poor survival rate. Thymic carcinoma is divided into subtypes, depending on the types of cells in which the cancer began. Also called type C thymoma.
A Mammotome device is a vacuum assisted breast biopsy device that uses image guidance such as x-ray, ultrasound and/or MRI to perform breast biopsies. A biopsy using a Mammotome device can be done on an outpatient basis with a local anesthetic. Mammotome is a registered trademark of Devicor Medical Products, Inc., part of Leica Biosystems.
Medullary breast carcinoma is a rare type of breast cancer that often can be treated successfully. It is marked by lymphocytes in and around the tumor that can be seen when viewed under a microscope.
Spindle cell carcinoma is a type of cancer that begins in the skin or in tissues that line or cover internal organs and that contains long spindle-shaped cells. It is also called sarcomatoid carcinoma.
Molecular risk assessment is a procedure in which biomarkers are used to estimate a person’s risk for developing cancer. Specific biomarkers may be linked to particular types of cancer.
Comedocarcinoma is one kind of breast cancer which is most commonly very early-stage which demonstrates central necrosis. It is usually a type of ductal carcinoma in situ. Comedo carcinomas are usually non-infiltrating and intraductal tumors. However, there have been accounts of comedocarcinoma which has then diversified into other cell types and developed into infiltrating (invasive) ductal carcinoma. Recurrence and survival rates differ for invasive breast cancer which has originated as comedocarcinoma compared with other types of cancer cells.
Lobular carcinoma in situ (LCIS) is an incidental microscopic finding with characteristic cellular morphology and multifocal tissue patterns. The condition is a laboratory diagnosis and refers to unusual cells in the lobules of the breast. The lobules and acini of the terminal duct-lobular unit (TDLU), the basic functional unit of the breast, may become distorted and undergo expansion due to the abnormal proliferation of cells comprising the structure. These changes represent a spectrum of atypical epithelial lesions that are broadly referred to as lobular neoplasia (LN).
